Company Overview and News
Data-center REIT Digital Realty Trust Inc. (DLR - Free Report) is on an expansion spree. The company is set to acquire around 424 acres on the western side of the Dulles International Airport, per a report from Loudoun Times-Mirror. It will reportedly shell out $236.5 million for purchasing the land from the Metropolitan Washington Airports Authority (MWAA). The transaction, which now awaits approvals from the MWAA Strategic Development Committee and the company’s board of directors, will likely close between Sep 28 and Oct 12.
CONE EQIX COR MDPEB DLR MDP
On a busy week of economic data and hurricane-related disruptions, US equities advanced 1% while real estate equities finished roughly flat. Housing-related categories await the impact of Hurricane Florence.
HD BAMGF DRE EQIX LEN CG CLGX MDC BAMKF BAM
Digital Realty Trust (NYSE:DLR) is offering direct, private access to Salesforce’s (NYSE:CRM) platform, the leading CRM solution worldwide, through Digital Realty Service Exchange in 15 metros worldwide. The move comes as part of the company’s effort to grow its business and lure customers, and ultimately boost DLR stock.
EQIX CRM CONE COR DLR
Digital Realty Trust, Inc. (DLR - Free Report) is offering direct, private access to Salesforce platform, the leading CRM solution worldwide, through Digital Realty Service Exchange in 15 metros worldwide. The move comes as part of the company’s effort to grow its business and lure customers. Particularly, this access to Salesforce is being offered in Amsterdam, Ashburn, Atlanta, Boston, Chicago, Frankfurt, Dallas, London and Los Angeles.
EQIX CG CONE COR DLR
2018-09-07 investorplace - 1
Like oxpeckers on a rhinoceros, the cloud era has spawned a number of companies that feed off the Cloud Czars, do their scut work and help the ecosystem work. Many, like Equinix (NASDAQ:EQIX), are good investments, albeit without the steady predictable growth of the companies they serve. Others, like Cloudera (NYSE:CLDR), are dicier propositions, as Cloudera stock is still trading at a 31% discount to its first trade as a public company, $18.
AMZN EQIX CLDR BOX MSFT INTC RHT
As Facebook (NASDAQ:FB) COO Sheryl Sandberg and Twitter (NASDAQ:TWTR) CEO Jack Dorsey faced a grilling before the Senate Sept. 5, investors were asking if the cloud party is ending and whether government is killing it.
IBM FB EQIX GOOG VMW VZA PTC BABA AMZN DVMT T GOOGL 0700 AAPL VZ MSFT BIDU
Data-center REITs are on a roll and over the past four quarters have led the REIT industry in terms of funds from operations (FFO) growth, per a recent report from REIT.com. In fact, their FFO has grown 35% from the year-ago tally and 8.1% in the second quarter. Particularly, demand from hyper-scale cloud users is high and has resulted in more than 177 megawatts (MW) of net absorption in the first half of 2018 even amid substantial new supply, per a report from CBRE Group Inc.
CONE CBG EQIX COR NVMI CBRE SMG
Equinix, Inc. (EQIX - Free Report) recently announced a partnership with VMware to offer private and secure connection to VMware Cloud, using Amazon Web Services (AWS), throughout Equinix’s International Business Exchange (IBX) data centers, globally.
EQIX NVMI VICI PSB SMG
In an effort to leverage on the rising demand for data-center space in Garland, data-center REIT Digital Realty Trust Inc. (DLR - Free Report) is planning to expand its project in the area. The company, which already received an approval last summer for developing a data-center campus, worth $1 billion, on a 47.5-acre site, has recently received the city authority’s approval for expansion of this project.
CONE EQIX COR DLR
2018-08-21 247wallst - 1
Think about the sheer amount of computing and data storage that goes on every single day. Then ponder the incredible amount of content streaming that goes on every day, both audio and video. Over-the-top streaming services like Hulu dominate younger demographics, and that is a reality that is changing the face of entertainment.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to EQIX / Equinix, Inc. on message board site Silicon Investor.
|Equinix Inc. - EQIX||Equinix Inc. - EQIX||Equinix Inc. - EQIX||RAX DLR EQIX - curious anomaly||RAX DLR EQIX - curious anomaly||RAX DLR EQIX - curious anomaly|
|Equinix (EQIX)||Equinix (EQIX)||Equinix (EQIX)|
as of ET